- 1) Messina, M. J., Persky, V., Setchell, K. D. R., and Barnes, S., Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer, 21, 113–131 (1994).
- 2) Liggins, J., Bluck, L. J. C., Runswick, S., Atkinson, C., Coward, W. A., and Bingham, S. A., Daidzein and genistein contents of vegetables. Br. J. Nutr., 84, 717–725 (2000).
- 3) Messina, M., and Barnes, S., The roles of soy products in reducing cancer risk. J. Natl. Cancer Inst., 83, 541–546 (1991).
- 4) Anthony, M. S., Soy and cardiovascular disease: cholesterol lowering and beyond. J. Nutr., 130, 662S–663S (2000).
- 5) Goodman-Gruen, D., and Kitz-Silverstein, D., Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J. Nutr., 131, 1202–1206 (2001).
- 6) Choi, Y. S., Kim, J. H., and Yoon, D. H., Effects of soy extract and sex on serum and liver lipid levels of the rat. Food Sci. Biotechnol., 11, 10–13 (2002).
- 7) Alekel, D. L., Germain, A. S., Peterson, C. T., Hanson, K. B., Stewart, J. W., and Toda, T., Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am. J. Clin. Nutr., 72, 844–852 (2000).
- 8) Somekawa, Y., Chiguchi, M., Ishibashi, T., and Aso, T., Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet. Gynecol., 97, 109–115 (2001).
- 9) Messina, M., Soyfoods and soybean phyto-oestrogens (isoflavones) as possible alternative to hormone replacement therapy (HRT). Eur. J. Cancer, 36, 71S–72S (2000).
- 10) Kapiotis, S., Hermann, M., Held, I., Seelos, C., Ehringer, H., and Gmeiner, B. M., Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler. Thromb. Vasc. Biol., 17, 2868–2874 (1997).
- 11) Anderson, J. J. B., and Garner, S. C., The effects of phytoestrogens on bone. Nutr. Rev., 17, 1617–1632 (1997).
- 12) Herman, C., Adlercreutz, T., Goldin, B. R., Gorbach, S. L., Höckerstedt, K. A. V., Watanabe, S., Hämäläinen, E. K., Markkanen, M. H., Mäkelä, T. H., Wahala, K. T., Hase, T. A., and Fotsis, T., Soybean phytoestrogen intake and cancer risk. J. Nutr., 125, 757S–770S (1995).
- 13) Wangen, K. E., Duncan, A. M., Xu, X., and Kurzer, M. S., Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am. J. Clin. Nutr., 73, 225–231 (2001).
- 14) Merz-Demlow, B. E., Duncan, A. M., Wangen, K. E., Xu, X., Carr, T. P., Phipps, W. R., and Kurzer, M. S., Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am. J. Clin. Nutr., 71, 1462–1469 (2000).
- 15) Sung, J. H., Screening, identification and inhibition kinetics of HMG-CoA reductase inhibitors in Korean soybean paste. [dissertation], Seoul National University, Seoul, Koera (2002).
- 16) Frimpong, K., Darnay, B. G., and Rodwell, V. W., Syrian hamster 3-hydroxy-3-methylglutaryl-coenzyme A reductase expressed in Escherichia coli: Production of homogeneous protein. Protein Expression Purif., 4, 337–344 (1993).
- 17) Markham, K. R., Chemical methods used in flavonoids structure elucidation. In “Techniques of Flavonoid Identification”, ed. Markham, K. R., Academic Press, New York, pp. 62–71 (1982).
- 18) Ikan, P., Acetogenins, flavonoids. In “Natural Products: A Laboratory Guide”, ed. Ikan, P., Academic Press, London, pp. 1–22 (1991).
- 19) Breton, M., Precigoux, G., Courseille, C., and Hospital, M., Génisteine. Acta Crystallogr. B, 31, 921–923 (1975).
- 20) Sirtori, C. R., Lovati, M. R., Manzoni, C., Monetti, M., Pazzucon, F., and Gatti, E., Soy and cholesterol reduction: Clinical experience. J. Nutr., 125, 598S–605S (1995).
- 21) Caroll, K. K., and Kurowska, E. M., Soy consumption and cholesterol reduction: review of animal and human studies. J. Nutr., 125, 594S–597S (1995).
- 22) Potter, S. M., Soy protein and cardiovascular disease: the impact of bioactive components in soy. Nutr. Rev., 56, 231–235 (1998).
- 23) Endo, A., Kuroda, M., and Tanzawa, K., Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. FEBS Lett., 72, 323–326 (1976).
- 24) Adlercreutz, H., Fotsis, T., Watanabe, S., Lampe, J., Wahala, K., Makela, T., and Hase, T., Determination of lignans and isoflavonoids in plasma by isotope dilution GC/MS. Cancer Detect. Prevent., 18, 259–271 (1994).
- 25) Xu, X., Harris, K. S., Wang, H. J., Murphy, P. A., and Hendrich, S., Bioavailability of soybean isoflavones depends upon gut microflora in women. J. Nutr., 125, 2307–2315 (1995).
- 26) Morton, M. S., Matos-Ferreira, A., Abranches-Monteiro, L., Correia, R., Blacklock, N., Chan, P. S. F., Cheng, C., Lloyd, S., Chieh-ping, W., and Griffiths, K., Measurement and metabolism of isoflavonoids and lignans in the human male. Cancer Lett., 114, 145–151 (1997).
Full access
Isoflavones Inhibit 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase in Vitro
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.